FDA APPROVES EDWARDS LIFESCIENCES' SAPIEN M3 MITRAL VALVE REPLACEMENT SYSTEM AS FIRST TRANSSEPTAL TRANSCATHETER THERAPY

Reuters · 2d ago

Please log in to view news